Cargando…

Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells

Detalles Bibliográficos
Autores principales: Eskandarpour, Malihe, Zhang, Xiaozhe, Micera, Alessandra, Zaher, Sarah, Larkin, Frank D. P., Nunn, Miles, Bonini, Stefano, Weston‐Davies, Wynne, Calder, Virginia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292376/
https://www.ncbi.nlm.nih.gov/pubmed/34614221
http://dx.doi.org/10.1111/all.15128
_version_ 1784749355107876864
author Eskandarpour, Malihe
Zhang, Xiaozhe
Micera, Alessandra
Zaher, Sarah
Larkin, Frank D. P.
Nunn, Miles
Bonini, Stefano
Weston‐Davies, Wynne
Calder, Virginia L.
author_facet Eskandarpour, Malihe
Zhang, Xiaozhe
Micera, Alessandra
Zaher, Sarah
Larkin, Frank D. P.
Nunn, Miles
Bonini, Stefano
Weston‐Davies, Wynne
Calder, Virginia L.
author_sort Eskandarpour, Malihe
collection PubMed
description
format Online
Article
Text
id pubmed-9292376
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92923762022-07-20 Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells Eskandarpour, Malihe Zhang, Xiaozhe Micera, Alessandra Zaher, Sarah Larkin, Frank D. P. Nunn, Miles Bonini, Stefano Weston‐Davies, Wynne Calder, Virginia L. Allergy Letters John Wiley and Sons Inc. 2021-10-15 2022-02 /pmc/articles/PMC9292376/ /pubmed/34614221 http://dx.doi.org/10.1111/all.15128 Text en © 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters
Eskandarpour, Malihe
Zhang, Xiaozhe
Micera, Alessandra
Zaher, Sarah
Larkin, Frank D. P.
Nunn, Miles
Bonini, Stefano
Weston‐Davies, Wynne
Calder, Virginia L.
Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
title Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
title_full Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
title_fullStr Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
title_full_unstemmed Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
title_short Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
title_sort allergic eye disease: blocking ltb4/c5 in vivo suppressed disease and th2 & th9 cells
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292376/
https://www.ncbi.nlm.nih.gov/pubmed/34614221
http://dx.doi.org/10.1111/all.15128
work_keys_str_mv AT eskandarpourmalihe allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT zhangxiaozhe allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT miceraalessandra allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT zahersarah allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT larkinfrankdp allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT nunnmiles allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT boninistefano allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT westondavieswynne allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells
AT caldervirginial allergiceyediseaseblockingltb4c5invivosuppresseddiseaseandth2th9cells